Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-07-02 @ 11:03 PM
Study NCT ID:
NCT05113459
Status:
UNKNOWN
Last Update Posted:
2021-11-09
First Post:
2021-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）
Sponsor:
Guoxin Li
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RC48-C018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None